CLINICAL_TRIALS
trial_result
· 2021-11-09
Clinical Trial Update: Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults [Phase 2]
Summary
Phase 2 trial update of the chikungunya vaccine PXVX0317 CHIKV-VLP in healthy adults has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bavarian Nordic | Conditions: Chikungunya Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-11-09